Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Methamphetamine Use Disorder clinical trials
Every US clinical trial registered for Methamphetamine Use Disorder — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
13 US clinical trials · 8 currently recruiting
The research picture
Methamphetamine Use Disorder has 13 registered US clinical trials, 8 of them open to new participants right now — about 62% of the total.
- 8
- recruiting participants now
- 62%
- of trials open to enrollment
- 0
- in Phase 3–4 (later-stage)
- 2
- top sponsor: William Stoops
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Non-Abstinence Outcomes in Methamphetamine Use Disorder
William Stoops
NCT07226596
Methamphetamine Cue-reactivity
Icahn School of Medicine at Mount Sinai
NCT07086014
Methamphetamine and Troriluzole
William Stoops
NCT06989853
Deep TMS of Neural Circuits Associated With Stimulant Use Disorder
Stanford University
NCT06578429
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
University of Colorado, Denver
NCT06320366
Psilocybin for Methamphetamine Addiction
Kevin Murnane
NCT06899594
A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder
The University of Texas Health Science Center, Houston
NCT06712446
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
Nicky Mehtani, MD, MPH
NCT06538285
Tirzepatide for Obesity and Meth Use Disorder
University of Texas Southwestern Medical Center
NCT06745128
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
University of Wisconsin, Madison
NCT05322954
Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder
University of Colorado, Denver
NCT05558358
Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM
Glenn-Milo Santos
NCT04791969
Mirtazapine and Methamphetamine Drug-drug Interaction Study
San Francisco Department of Public Health
NCT04614584
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 3 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Methamphetamine Use Disorder Trial Landscape
ClinicalTrials.gov lists 13 US studies indexed under Methamphetamine Use Disorder, and 8 of those are currently open to recruitment — roughly 62% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Methamphetamine Use Disorder shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 8 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Methamphetamine Use Disorder is led by William Stoops with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 13 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Methamphetamine Use Disorder?
PlainTrial tracks 13 US clinical trials for Methamphetamine Use Disorder, of which 8 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Methamphetamine Use Disorder?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.